Research news of note last week included US biotech Crinetics Pharmaceuticals releasing new Phase III data on its acromegaly drug candidate Palsonify (paltusotine). AstraZeneca announced positive ...

As of July 18, 2025, the Food and Drug Administration (FDA) said it has received three reports of fatal acute liver failure ...

US pharma major Bristol Myers Squibb’s shares remained steady, despite the company reporting disappointing results from its ...

The European Commission granted conditional marketing authorization for Ezmekly (mirdametinib) for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in pediatric and adult patients ...

The market for selective estrogen receptor modulators, or SERMs, is poised for considerable growth over the next decade, ...

In what is not exactly a win-win situation for the Indian generic firms, a recent federal court ruling in Delaware, USA, has ...

The European Medicines Agency has called for updated rules and processes to reflect growing use of artificial intelligence in ...

Danish allergy immunotherapy specialist ALK Abello has announced that the UK’s Medicines and Healthcare Products Regulatory ...

Oncologic Drugs Advisory Committee has voted against two proposed combination regimens containing GSK’s Blenrep (belantamab ...

Scottish biotech Trogenix has announced two senior appointments as the company advances its pipeline towards the clinic.

US healthcare giant Johnson & Johnson announced that the prestigious medical journal The Lancet has published positive ...

US biotech TRIO Pharmaceuticals has announced the appointment of Patrick Doyle as chief executive (CEO effective immediately.